Global Insomnia Industry Survey, Trends, Outlook, Overview and 2023 Forecast

Market Research Future adds new report of “Global Insomnia Market Research Report Forecast to 2023” it contains Company information, geographical data and Table of Content

Market Scenario:

Insomnia is a common sleep disorder characterized by difficulties in sleep. Insomnia can exist as it’s alone or conjugated with other psychiatric problems. Insomnia is most common is women and the severity may increase in conditions like pregnancy, postpartum, and menopause. The exact cause of insomnia is still a mystery. Many researches have shown that biological, behavioral and psychological factors are responsible for initiating of insomnia. Different types of treatment are available in the market- Pharmacological and non-pharmacological treatment. Global Insomnia market is driving due to increase in the number of insomnia patient across the globe, technological advances and many others. While lack of education and awareness is the major restraining factor for the growth of market.

Global insomnia market is expected to grow at a CAGR of 4.5% during forecasted period of 2017-2023.

Market Segmentation

Global Insomnia Market has been segmented on the basis of

  • On the basis of Types of Therapy; which comprises Pharmacological therapy which is further sub segmented into benzodiazepines, non-benzodiazepines, and melatonin receptor agonists. Non Pharmacological therapy which is sub segmented into Relaxation therapy, Cognitive Behavioral Therapy, Sleep Hygiene Education, Stimulus Control, Paradoxical Intention and Other.
  • On the basis of Drug Formulation; they are segmented as Capsules, Tablet and others.
  • On the basis of Condition of Diseases; they are poor quality of sleep, sleep maintenance and other.

Request a Sample Report @

Study Objectives Global Insomnia Market Research Report

  • To provide the Detail Overview of parent market.
  • To provide In-depth market segmentation and sub segmentations.
  • To provide insights about factors affecting the market growth
  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide Competitive landscape and key players in the market.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia Pacific and Middle East and Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global insomnia market.

Browse Report Details @

Key Players:

  • Eisai, Co. (Japan)
  • Pfizer, Inc. (US)
  • Merck & Co Inc. (US)
  • Sanofi (France)
  • Takeda Pharmaceutical Company (Japan)
  • Meda Consumer Healthcare Inc. (US)
  • Pernix Therapeutics (US)
  • Purdue Pharma L.P. (US)
  • Consumer Healthcare Inc. (Canada)
  • Dainippon Sumitomo (Japan)
  • ECR Pharmaceuticals (US)
  • Flynn Pharma (UK)
  • Johnson & Johnson (US)
  • Astellas (UK)
  • Biocodex S A (France)
  • Neurim (Switzerland)
  • SkyePharma (UK)
  • Vanda Pharmaceuticals Inc. (US)

Intended Audience

  • Manufacturing and packaging industries.
  • Insomnia devices and drug manufacturers
  • Insomnia devices and drug suppliers
  • Biotechnology Companies
  • Bio-Pharmaceutical Companies
  • Research and Development (R&D) Companies
  • Government Research Laboratories
  • Medical Research Institutes

Request Table of Contents for this Report @

Regional Analysis

On regional basis the global insomnia market is segmented into four regions- North America, Europe, Asia Pacific and Middle East and Africa.  Due to introduction of new technology and new treatments North America is has the highest market for insomnia followed by Europe. Increasing stress is the major problem for increasing the insomnia market in North America and Europe. Asia Pacific and Middle East and Africa have the lowest market for insomnia.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.


Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312


%d bloggers like this: